Bank of America issued a buy rating on the stock of Parabilis Medicines on October 16, 2026.
1 report, 1 independent
Updated 00:00
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Bank of America issued a buy rating on the stock of Parabilis Medicines on October 16, 2026.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Bank of America
American multinational banking and financial services corporation
Related events
- Bank of America boosted its price target and gave a buy rating for Guardian Pharmacy Services, Inc. on September 15, 2026. Truist Financial also boosted its target price and gave a buy rating on the same day.
- Bank of America reiterated a buy rating and UBS raised its target price and gave a buy rating for Bread Financial.
- Bank of America issued a buy rating for United Rentals.
- Bank of America maintained its 'buy' rating on Corteva on October 5, 2026.
- Bank of America influenced stock rating and target price for Commercial Metals Company, with MarketBeat aggregating the data.